Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saedis Saevarsdottir

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Annals of the Rheumatic Diseases|June 21, 2015
Does a family history of RA influence the clinical presentation and treatment response in RA?Thomas Frisell, Saedis Saevarsdottir, Johan Askling
Nature Reviews. Rheumatology|April 22, 2016
Family history of rheumatoid arthritis: an old concept with new developmentsThomas Frisell, Saedis Saevarsdottir, Johan Askling
The Journal of Rheumatology|July 5, 2007
Patients with rheumatoid arthritis have higher levels of mannan-binding lectin than their first-degree relatives and unrelated controlsSaedis Saevarsdottir, Kristjan Steinsson, Gerdur Grondal, et al.
Annals of the Rheumatic Diseases|April 25, 2013
Thyroxin substitution and the risk of developing rheumatoid arthritis; results from the Swedish population-based EIRA studyCamilla Bengtsson, Leonid Padyukov, Henrik Källberg, et al.
JAMA Network Open|January 16, 2019
Risk of Thyroxine-Treated Autoimmune Thyroid Disease Associated With Disease Onset in Patients With Rheumatoid ArthritisKristin Waldenlind, Saedis Saevarsdottir, Camilla Bengtsson, et al.
RMD Open|July 17, 2020
Does autoimmune thyroid disease affect rheumatoid arthritis disease activity or response to methotrexate?Kristin Waldenlind, Bénédicte Delcoigne, Saedis Saevarsdottir, et al.
Journal of Internal Medicine|November 22, 2023
Disease-modifying antirheumatic drugs and risk of thyroxine-treated autoimmune thyroid disease in patients with rheumatoid arthritisKristin Waldenlind, Bénédicte Delcoigne, Saedis Saevarsdottir, et al.
Rheumatology (Oxford, England)|December 17, 2020
Comorbidities at diagnosis of rheumatoid arthritis: a population-based case-control studyLiselotte Tidblad, Helga Westerlind, Bénédicte Delcoigne, et al.
RMD Open|December 23, 2022
Comorbidities and treatment patterns in early rheumatoid arthritis: a nationwide Swedish studyLiselotte Tidblad, Helga Westerlind, Benedicte Delcoigne, et al.
RMD Open|December 20, 2023
Comorbidities and chance of remission in patients with early rheumatoid arthritis receiving methotrexate as first-line therapy: a Swedish observational nationwide studyLiselotte Tidblad, Helga Westerlind, Bénédicte Delcoigne, et al.
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Annals of the Rheumatic Diseases|June 21, 2015
Does a family history of RA influence the clinical presentation and treatment response in RA?Thomas Frisell, Saedis Saevarsdottir, Johan Askling
Nature Reviews. Rheumatology|April 22, 2016
Family history of rheumatoid arthritis: an old concept with new developmentsThomas Frisell, Saedis Saevarsdottir, Johan Askling
The Journal of Rheumatology|July 5, 2007
Patients with rheumatoid arthritis have higher levels of mannan-binding lectin than their first-degree relatives and unrelated controlsSaedis Saevarsdottir, Kristjan Steinsson, Gerdur Grondal, et al.
Annals of the Rheumatic Diseases|April 25, 2013
Thyroxin substitution and the risk of developing rheumatoid arthritis; results from the Swedish population-based EIRA studyCamilla Bengtsson, Leonid Padyukov, Henrik Källberg, et al.
JAMA Network Open|January 16, 2019
Risk of Thyroxine-Treated Autoimmune Thyroid Disease Associated With Disease Onset in Patients With Rheumatoid ArthritisKristin Waldenlind, Saedis Saevarsdottir, Camilla Bengtsson, et al.
RMD Open|July 17, 2020
Does autoimmune thyroid disease affect rheumatoid arthritis disease activity or response to methotrexate?Kristin Waldenlind, Bénédicte Delcoigne, Saedis Saevarsdottir, et al.
Journal of Internal Medicine|November 22, 2023
Disease-modifying antirheumatic drugs and risk of thyroxine-treated autoimmune thyroid disease in patients with rheumatoid arthritisKristin Waldenlind, Bénédicte Delcoigne, Saedis Saevarsdottir, et al.
Rheumatology (Oxford, England)|December 17, 2020
Comorbidities at diagnosis of rheumatoid arthritis: a population-based case-control studyLiselotte Tidblad, Helga Westerlind, Bénédicte Delcoigne, et al.
RMD Open|December 23, 2022
Comorbidities and treatment patterns in early rheumatoid arthritis: a nationwide Swedish studyLiselotte Tidblad, Helga Westerlind, Benedicte Delcoigne, et al.
RMD Open|December 20, 2023
Comorbidities and chance of remission in patients with early rheumatoid arthritis receiving methotrexate as first-line therapy: a Swedish observational nationwide studyLiselotte Tidblad, Helga Westerlind, Bénédicte Delcoigne, et al.
Pageof 11